North America and Europe Celiac Disease Market - Industry Trends and Forecast to 2031

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	317 Pages	Data Bridge Market Research	December, 2023	DAABD18458989

Best Price Guarantee
Price	from $3,500
Length	317 Pages
Publisher	Data Bridge Market Research
Published Date	December, 2023
SKU	DAABD18458989

North America and Europe Celiac Disease Market - Industry Trends and Forecast to 2031

The North America celiac disease market is expected to reach USD 193,364.33 thousand by 2031 from USD 94,325.34 thousand in 2023, growing at a CAGR of 9.8% during the forecast period of 2024 to 2031.
The Europe celiac disease market is expected to reach USD 150,949.09 thousand by 2031 from USD 78,786.35 thousand in 2023, growing at a CAGR of 8.8% during the forecast period of 2024 to 2031.
Market Segmentation
North America and Europe celiac disease market, By Treatment type (Corticosteriods, Immunosuppressants, and Others), Disease Type (Classical Celiac Disease, Non-Classical Celiac Disease, Refractory Celiac Disease, Potential Celiac Disease, and Dermatitis Herpetiformis), Drug Type (Generics and Branded), Prescription Type (Prescription and Over The Counter), Dosage Form (Tablet, Capsules, Injection, and Other), Route of Administration (Oral, Intravenous, and Topical), Population Type (Children, Adults, and Geriatric), End User (Hospitals, Clinics, Diagnostic Centres, Home Care Settings, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others) - Industry Trends and Forecast to 2031

Overview of North America and Europe Celiac Disease Market Dynamics

Driver
• Increasing prevalence of celiac disease

Restrain

• Complexity of celiac disease

Opportunity

• Emerging biological therapies for celiac disease

Market Players

Some of the major market players operating in the North America and Europe celiac disease market are:

• Takeda Pharmaceutical Company Limited
• Salix Pharmaceuticals (subsidiary of Bausch Health Companies Inc.)
• Tillotts Pharma AG
• GSK plc.
• ImmunogenX, Inc.
• Janssen Pharmaceuticals, Inc. (subsidiary of Johnson & Johnson Services, Inc.)
• Teva Pharmaceuticals USA, Inc.
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Amgen Inc.
• AstraZeneca
• Novartis AG
• AdvaCare Pharma
• ANOKION
• Topas Therapeutics
• Immunic Therapeutics
• Equillium Bio.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The North America And Europe Celiac Disease Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Treatment Type Lifeline Curve For The North America Celiac Disease Market; 2.8 Treatment Type Lifeline Curve The Europe Celiac Disease Market; 2.9 Primary Interviews With Key Opinion Leaders; 2.10 Dbmr Market Position Grid; 2.11 Market End User Coverage Grid; 2.12 Vendor Share Analysis; 2.13 Secondary Sources; 2.14 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestal Analysis; 4.2 Porters 5 Forces; 4.3 Epidemiology
5 Pipeline Analysis
6 North America And Europe Celiac Disease Market, Regulatory Framework: 6.1 Regulations In North America; 6.1.1 U.S.; 6.1.2 Canada; 6.2 Regulations In Europe; 6.2.1 European Union (Eu); 6.2.2 U.K.
7 Market Overview: 7.1 Drivers; 7.1.1 Increasing Prevalence Of Celiac Disease; 7.1.2 Rising Consumption Of Gluten-containing Products; 7.1.3 Increasing Research And Development For Celiac Disease Treatments; 7.1.4 Growing Awareness About Celiac Disease; 7.2 Restraints; 7.2.1 Complexity Of Celiac Disease; 7.2.2 Limited Treatment Options For Celiac Disease; 7.3 Opportunities; 7.3.1 Emerging Biological Therapies For Celiac Disease; 7.3.2 Rising Advancements In Diagnostic Approaches Of Celiac Disease; 7.3.3 Strategic Collaboration For Commercialization Of Novel Therapies For Celiac Disease; 7.4 Challenges; 7.4.1 Patient Adherence To Gluten-free Diet; 7.4.2 Adverse Effects Associated With Medications Used For Celiac Disease Treatment
8 North America And Europe Celiac Disease Market, By Treatment Type: 8.1 Overview; 8.2 Corticosteriods; 8.2.1 Prednisone; 8.2.2 .Budesonide; 8.2.3 Betamethasone; 8.2.4 Clobetasone Butyrate; 8.2.5 Others; 8.3 Immunosuppressants; 8.3.1 Azathioprine; 8.3.2 Infliximab; 8.3.3 Cyclosporine; 8.3.4 Cladribine; 8.3.5 Others; 8.4 Others
9 North America And Europe Celiac Disease Market, By Disease Type: 9.1 Overview; 9.2 Refractory Celiac Disease; 9.2.1 Type I; 9.2.2 Type Ii; 9.3 Dermatitis Herpetiformis; 9.4 Potential Celiac Disease; 9.5 Classical Celiac Disease; 9.6 Non-classical Celiac Disease
10 North America And Europe Celiac Disease Market, By Drug Type: 10.1 Overview; 10.2 Generics; 10.3 Branded
11 North America And Europe Celiac Disease Market, By Prescription Type: 11.1 Overview; 11.2 Prescription; 11.3 Over The Counter
12 North America And Europe Celiac Disease Market, By Dosage Form: 12.1 Overview; 12.2 Tablet; 12.3 Capsules; 12.4 Injections; 12.5 Other
13 North America And Europe Celiac Disease Market, By Route Of Administration: 13.1 Overview; 13.2 Oral; 13.2.1 Tablet; 13.2.2 Capsules; 13.2.3 Others; 13.3 Intravenous; 13.4 Topical
14 North America And Europe Celiac Disease Market, By Population Type: 14.1 Overview; 14.2 Adults; 14.2.1 Female; 14.2.2 Male; 14.3 Children; 14.4 Geriatric; 14.4.1 Female; 14.4.2 Male
15 North America And Europe Celiac Disease Market, By End User: 15.1 Overview; 15.2 Hospitals; 15.3 Clinics; 15.4 Home Care Settings; 15.5 Others
16 North America And Europe Celiac Disease Market, By Distribution Channel: 16.1 Overview; 16.2 Hospital Pharmacy; 16.3 Retail Pharmacy; 16.4 Online Pharmacy; 16.5 Others
17 North America And Europe Celiac Disease Market, By Geography: 17.1 North America; 17.1.1 U.S.; 17.1.2 Canada; 17.1.3 Mexico; 17.2 Europe; 17.2.1 Germany; 17.2.2 France; 17.2.3 Italy; 17.2.4 Spain; 17.2.5 U.K.; 17.2.6 Switzerland; 17.2.7 Netherlands; 17.2.8 Russia; 17.2.9 Turkey; 17.2.10 Poland; 17.2.11 Sweden; 17.2.12 Belgium; 17.2.13 Denmark; 17.2.14 Finland; 17.2.15 Norway; 17.2.16 Rest Of Europe
18 North America Celiac Disease Market: Company Landscape: 18.1 Company Share Analysis: North America
19 Europe Celiac Disease Market: Company Landscape: 19.1 Company Share Analysis: Europe
20 Swot Analysis
21 Company Profiles: 21.1 Gsk Plc.; 21.1.1 Company Snapshot; 21.1.2 Revenue Analysis; 21.1.3 Product Portfolio; 21.1.4 Recent Development; 21.2 Janssen Pharmaceuticals, Inc. (A Subsidiary Of Johnson & Johnson Services, Inc.); 21.2.1 Company Snapshot; 21.2.2 Revenue Analysis; 21.2.3 Product Portfolio; 21.2.4 Recent Development; 21.3 Pfizer Inc.; 21.3.1 Company Snapshot; 21.3.2 Revenue Analysis; 21.3.3 Product Portfolio; 21.3.4 Recent Development; 21.4 Teva Pharmaceuticals Usa, Inc.; 21.4.1 Company Snapshot; 21.4.2 Revenue Analysis; 21.4.3 Product Portfolio; 21.4.4 Recent Development; 21.5 Novartis Ag; 21.5.1 Company Snapshot; 21.5.2 Revenue Analysis; 21.5.3 Product Portfolio; 21.5.4 Recent Development; 21.6 Advacare Pharma; 21.6.1 Company Snapshot; 21.6.2 Product Portfolio; 21.6.3 Recent Development; 21.7 Amgen Inc.; 21.7.1 Company Snapshot; 21.7.2 Revenue Analysis; 21.7.3 Product Portfolio; 21.7.4 Recent Development; 21.8 Anokion; 21.8.1 Company Snapshot; 21.8.2 Product Portfolio; 21.8.3 Recent Development; 21.9 Equillium Bio.; 21.9.1 Company Snapshot; 21.9.2 Product Portfolio; 21.9.3 Recent Development; 21.10 Immunic Therapeutics; 21.10.1 Company Snapshot; 21.10.2 Product Portfolio; 21.10.3 Recent Development; 21.11 Immunogenx, Inc.; 21.11.1 Company Snapshot; 21.11.2 Product Portfolio; 21.11.3 Recent Development; 21.12 Salix Pharmaceuticals (Subsidiary Of Bausch Health Companies Inc.); 21.12.1 Company Snapshot; 21.12.2 Revenue Analysis Of Parent Company; 21.12.3 Product Portfolio; 21.12.4 Recent Development; 21.13 Takeda Pharmaceutical Company Limited; 21.13.1 Company Snapshot; 21.13.2 Revenue Analysis; 21.13.3 Product Portfolio; 21.13.4 Recent Development; 21.14 Tillotts Pharma Ag; 21.14.1 Company Snapshot; 21.14.2 Product Portfolio; 21.14.3 Recent Development; 21.15 Topas Therapeutics; 21.15.1 Company Snapshot; 21.15.2 Product Portfolio; 21.15.3 Recent Development
22 Questionnaire
23 Related Reports
List Of Tables: Table 1 Pipeline Analysis For North America And Europe Celiac Disease Market; Table 2 North America Celiac Disease Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 3 Europe Celiac Disease Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 4 North America Corticosteriods In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 5 North America Corticosteriods In Celiac Disease Market, By Type, 2022-2031 (Units); Table 6 Europe Corticosteriods In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 7 Europe Corticosteriods In Celiac Disease Market, By Product, 2022-2031 (Usd Thousand); Table 8 North America Immunosuppressants In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 9 North America Immunosuppressants In Celiac Disease Market, By Type, 2022-2031 (Units); Table 10 Europe Immunosuppressants In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 11 Europe Immunosuppressants In Celiac Disease Market, By Type, 2022-2031 (Units); Table 12 North America Celiac Disease Market, By Disease Type, 2022-2031 (Usd Thousand); Table 13 Europe Celiac Disease Market, By Disease Type, 2022-2031 (Usd Thousand); Table 14 North America Refractory Celiac Disease In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 15 Europe Refractory Celiac Disease In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 16 North America Celiac Disease Market, By Drug Type, 2022-2031 (Usd Thousand); Table 17 Europe Celiac Disease Market, By Drug Type, 2022-2031 (Usd Thousand); Table 18 North America Celiac Disease Market, By Prescription Type, 2022-2031 (Usd Thousand); Table 19 Europe Celiac Disease Market, By Prescription Type, 2022-2031 (Usd Thousand); Table 20 North America Celiac Disease Market, By Dosage Form, 2022-2031 (Usd Thousand); Table 21 Europe Celiac Disease Market, By Dosage Form, 2022-2031 (Usd Thousand); Table 22 North America Celiac Disease Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 23 Europe Celiac Disease Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 24 North America Corticosteriods In Celiac Disease Market, By Product, 2022-2031 (Usd Thousand); Table 25 Europe Corticosteriods In Celiac Disease Market, By Product, 2022-2031 (Usd Thousand); Table 26 North America Celiac Disease Market, By Population Type, 2022-2031 (Usd Thousand); Table 27 Europe Celiac Disease Market, By Population Type, 2022-2031 (Usd Thousand); Table 28 North America Adults In Celiac Disease Market, By Population Type, 2022-2031 (Usd Thousand); Table 29 Europe Adults In Celiac Disease Market, By Population Type, 2022-2031 (Usd Thousand); Table 30 North America Geriatric In Celiac Disease Market, By Population Type, 2022-2031 (Usd Thousand); Table 31 Europe Geraitric In Celiac Disease Market, By Population Type, 2022-2031 (Usd Thousand); Table 32 North America Celiac Disease Market, By End User, 2022-2031 (Usd Thousand); Table 33 Europe Celiac Disease Market, By End User, 2022-2031 (Usd Thousand); Table 34 North America Celiac Disease Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 35 Europe Celiac Disease Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 36 North America Celiac Disease Market, By Country, 2022-2031 (Usd Thousand); Table 37 U.S. Celiac Disease Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 38 U.S. Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 39 U.S. Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Units); Table 40 U.S. Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Asp Per Unit); Table 41 U.S. Immunosuppressants In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 42 U.S. Immunosuppressants In Celiac Disease Market, By Type , 2022-2031 (Units); Table 43 U.S. Immunosuppressants In Celiac Disease Market, By Type, 2022-2031 (Asp Per Unit); Table 44 U.S. Celiac Disease Market, By Diseases Type, 2022-2031 (Usd Thousand); Table 45 U.S. Refractory Celiac Disease In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 46 U.S. Celiac Disease Market, By Drug Type, 2022-2031 (Usd Thousand); Table 47 U.S. Celiac Disease Market, By Prescription Type, 2022-2031 (Usd Thousand); Table 48 U.S. Celiac Disease Market, By Dosage Form, 2022-2031 (Usd Thousand); Table 49 U.S. Celiac Disease Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 50 U.S. Oral In Celiac Disease Market, By Dosage Form, 2022-2031 (Usd Thousand); Table 51 U.S. Celiac Disease Market, By Population Type, 2022-2031 (Usd Thousand); Table 52 U.S. Adults In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 53 U.S. Geriatric In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 54 U.S. Celiac Disease Market, By End User, 2022-2031 (Usd Thousand); Table 55 U.S. Celiac Disease Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 56 Canada Celiac Disease Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 57 Canada Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 58 Canada Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Units); Table 59 Canada Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Asp Per Unit); Table 60 Canada Immunosuppressants In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 61 Canada Immunosuppressants In Celiac Disease Market, By Type , 2022-2031 (Units); Table 62 Canada Immunosuppressants In Celiac Disease Market, By Type, 2022-2031 (Asp Per Unit); Table 63 Canada Celiac Disease Market, By Diseases Type, 2022-2031 (Usd Thousand); Table 64 Canada Refractory Celiac Disease In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 65 Canada Celiac Disease Market, By Drug Type, 2022-2031 (Usd Thousand); Table 66 Canada Celiac Disease Market, By Prescription Type, 2022-2031 (Usd Thousand); Table 67 Canada Celiac Disease Market, By Dosage Form, 2022-2031 (Usd Thousand); Table 68 Canada Celiac Disease Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 69 Canada Oral In Celiac Disease Market, By Dosage Form, 2022-2031 (Usd Thousand); Table 70 Canada Celiac Disease Market, By Population Type, 2022-2031 (Usd Thousand); Table 71 Canada Adults In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 72 Canada Geriatric In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 73 Canada Celiac Disease Market, By End User, 2022-2031 (Usd Thousand); Table 74 Canada Celiac Disease Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 75 Mexico Celiac Disease Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 76 Mexico Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 77 Mexico Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Units); Table 78 Mexico Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Asp Per Unit); Table 79 Mexico Immunosuppressants In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 80 Mexico Immunosuppressants In Celiac Disease Market, By Type , 2022-2031 (Units); Table 81 Mexico Immunosuppressants In Celiac Disease Market, By Type, 2022-2031 (Asp Per Unit); Table 82 Mexico Celiac Disease Market, By Diseases Type, 2022-2031 (Usd Thousand); Table 83 Mexico Refractory Celiac Disease In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 84 Mexico Celiac Disease Market, By Drug Type, 2022-2031 (Usd Thousand); Table 85 Mexico Celiac Disease Market, By Prescription Type, 2022-2031 (Usd Thousand); Table 86 Mexico Celiac Disease Market, By Dosage Form, 2022-2031 (Usd Thousand); Table 87 Mexico Celiac Disease Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 88 Mexico Oral In Celiac Disease Market, By Dosage Form, 2022-2031 (Usd Thousand); Table 89 Mexico Celiac Disease Market, By Population Type, 2022-2031 (Usd Thousand); Table 90 Mexico Adults In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 91 Mexico Geriatric In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 92 Mexico Celiac Disease Market, By End User, 2022-2031 (Usd Thousand); Table 93 Mexico Celiac Disease Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 94 Europe Celiac Disease Market, By Country, 2022-2031 (Usd Thousand); Table 95 Germany Celiac Disease Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 96 Germany Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 97 Germany Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Units); Table 98 Germany Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Asp Per Unit); Table 99 Germany Immunosuppressants In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 100 Germany Immunosuppressants In Celiac Disease Market, By Type , 2022-2031 (Units); Table 101 Germany Immunosuppressants In Celiac Disease Market, By Type, 2022-2031 (Asp Per Unit); Table 102 Germany Celiac Disease Market, By Diseases Type, 2022-2031 (Usd Thousand); Table 103 Germany Refractory Celiac Disease In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 104 Germany Celiac Disease Market, By Drug Type, 2022-2031 (Usd Thousand); Table 105 Germany Celiac Disease Market, By Prescription Type, 2022-2031 (Usd Thousand); Table 106 Germany Celiac Disease Market, By Dosage Form, 2022-2031 (Usd Thousand); Table 107 Germany Celiac Disease Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 108 Germany Oral In Celiac Disease Market, By Dosage Form, 2022-2031 (Usd Thousand); Table 109 Germany Celiac Disease Market, By Population Type, 2022-2031 (Usd Thousand); Table 110 Germany Adults In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 111 Germany Geriatric In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 112 Germany Celiac Disease Market, By End User, 2022-2031 (Usd Thousand); Table 113 Germany Celiac Disease Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 114 France Celiac Disease Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 115 France Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 116 France Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Units); Table 117 France Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Asp Per Unit); Table 118 France Immunosuppressants In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 119 France Immunosuppressants In Celiac Disease Market, By Type , 2022-2031 (Units); Table 120 France Immunosuppressants In Celiac Disease Market, By Type, 2022-2031 (Asp Per Unit); Table 121 France Celiac Disease Market, By Diseases Type, 2022-2031 (Usd Thousand); Table 122 France Refractory Celiac Disease In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 123 France Celiac Disease Market, By Drug Type, 2022-2031 (Usd Thousand); Table 124 France Celiac Disease Market, By Prescription Type, 2022-2031 (Usd Thousand); Table 125 France Celiac Disease Market, By Dosage Form, 2022-2031 (Usd Thousand); Table 126 France Celiac Disease Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 127 France Oral In Celiac Disease Market, By Dosage Form, 2022-2031 (Usd Thousand); Table 128 France Celiac Disease Market, By Population Type, 2022-2031 (Usd Thousand); Table 129 France Adults In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 130 France Geriatric In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 131 France Celiac Disease Market, By End User, 2022-2031 (Usd Thousand); Table 132 France Celiac Disease Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 133 Italy Celiac Disease Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 134 Italy Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 135 Italy Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Units); Table 136 Italy Corticosteroids In Celiac Disease Market, By Type, 2022-2031 (Asp Per Unit); Table 137 Italy Immunosuppressants In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 138 Italy Immunosuppressants In Celiac Disease Market, By Type , 2022-2031 (Units); Table 139 Italy Immunosuppressants In Celiac Disease Market, By Type, 2022-2031 (Asp Per Unit); Table 140 Italy Celiac Disease Market, By Diseases Type, 2022-2031 (Usd Thousand); Table 141 Italy Refractory Celiac Disease In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 142 Italy Celiac Disease Market, By Drug Type, 2022-2031 (Usd Thousand); Table 143 Italy Celiac Disease Market, By Prescription Type, 2022-2031 (Usd Thousand); Table 144 Italy Celiac Disease Market, By Dosage Form, 2022-2031 (Usd Thousand); Table 145 Italy Celiac Disease Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 146 Italy Oral In Celiac Disease Market, By Dosage Form, 2022-2031 (Usd Thousand); Table 147 Italy Celiac Disease Market, By Population Type, 2022-2031 (Usd Thousand); Table 148 Italy Adults In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand); Table 149 Italy Geriatric In Celiac Disease Market, By Type, 2022-2031 (Usd Thousand)
List Of Figures: Figure 1 North America And Europe Celiac Disease Market: Segmentation; Figure 2 North America And Europe Celiac Disease Market: Data Triangulation; Figure 3 North America And Europe Celiac Disease Market: Droc Analysis; Figure 4 North America Celiac Disease Market: Regional Vs Country Market Analysis; Figure 5 Europe Celiac Disease Market: Regional Vs Country Market Analysis; Figure 6 North America Celiac Disease Market: Company Research Analysis; Figure 7 North America And Europe Celiac Disease Market: Interview Demographics; Figure 8 North America Celiac Disease Market: Dbmr Market Position Grid; Figure 9 Europe Celiac Disease Market: Dbmr Market Position Grid; Figure 10 North America Celiac Disease Market: Market End User Coverage Grid; Figure 11 Europe Celiac Disease Market: Market End User Coverage Grid; Figure 12 North America Celiac Disease Market: Vendor Share Analysis; Figure 13 Europe Celiac Disease Market: Vendor Share Analysis; Figure 14 North America And Europe Celiac Disease Market: Segmentation; Figure 15 The Increasing Prevalence Of Celiac Disease Is Driving The Growth Of The North America Celiac Disease Market In The Forecast Period Of 2024 To 2031; Figure 16 Rising Consumption Of Gluten-containing Products Is Driving The Growth Of The Europe Celiac Disease Market In The Forecast Period Of 2024 To 2031; Figure 17 Corticosteroids Segment Is Expected To Account For The Largest Share Of The North America Celiac Disease Market In The Forecast Period Of 2024 And 2031; Figure 18 Carticosteroids Segment Is Expected To Account For The Largest Share Of The Europe Celiac Disease Market In The Forecast Period Of 2024 And 2031; Figure 19 Drivers, Restraints, Opportunities, And Challenges Of The North America And Europe Celiac Disease Market; Figure 20 North America Celiac Disease Market: By Treatment Type, 2023; Figure 21 North America Celiac Disease Market: By Treatment Type, 2024-2031 (Usd Thousand); Figure 22 North America Celiac Disease Market: By Treatment Type, Cagr (2024-2031); Figure 23 North America Celiac Disease Market: By Treatment Type, Lifeline Curve; Figure 24 Europe Celiac Disease Market: By Treatment Type, 2023; Figure 25 Europe Celiac Disease Market: By Treatment Type, 2024-2031 (Usd Thousand); Figure 26 Europe Celiac Disease Market: By Treatment Type, Cagr (2024-2031); Figure 27 Europe Celiac Disease Market: By Treatment Type, Lifeline Curve; Figure 28 North America Celiac Disease Market: By Disease Type, 2023; Figure 29 North America Celiac Disease Market: By Disease Type, 2024-2031 (Usd Thousand); Figure 30 North America Celiac Disease Market: By Disease Type, Cagr (2024-2031); Figure 31 North America Celiac Disease Market: By Disease Type, Lifeline Curve; Figure 32 Europe Celiac Disease Market: By Disease Type, 2023; Figure 33 Europe Celiac Disease Market: By Disease Type, 2024-2031 (Usd Thousand); Figure 34 Europe Celiac Disease Market: By Disease Type, Cagr (2024-2031); Figure 35 Europe Celiac Disease Market: By Disease Type, Lifeline Curve; Figure 36 North America Celiac Disease Market: By Drug Type, 2023; Figure 37 North America Celiac Disease Market: By Drug Type, 2024-2031 (Usd Thousand); Figure 38 North America Celiac Disease Market: By Drug Type, Cagr (2024-2031); Figure 39 North America Celiac Disease Market: By Drug Type, Lifeline Curve; Figure 40 Europe Celiac Disease Market: By Drug Type, 2023; Figure 41 Europe Celiac Disease Market: By Drug Type, 2024-2031 (Usd Thousand); Figure 42 Europe Celiac Disease Market: By Drug Type, Cagr (2024-2031); Figure 43 Europe Celiac Disease Market: By Drug Type, Lifeline Curve; Figure 44 North America Celiac Disease Market: By Prescription Type, 2023; Figure 45 North America Celiac Disease Market: By Prescription Type, 2024-2031 (Usd Thousand); Figure 46 North America Celiac Disease Market: By Prescription Type, Cagr (2024-2031); Figure 47 North America Celiac Disease Market: By Prescription Type, Lifeline Curve; Figure 48 Europe Celiac Disease Market: By Prescription Type, 2023; Figure 49 Europe Celiac Disease Market: By Prescription Type, 2024-2031 (Usd Thousand); Figure 50 Europe Celiac Disease Market: By Prescription Type, Cagr (2024-2031); Figure 51 Europe Celiac Disease Market: By Prescription Type, Lifeline Curve; Figure 52 North America Celiac Disease Market: By Dosage Form, 2023; Figure 53 North America Celiac Disease Market: By Dosage Form, 2024-2031 (Usd Thousand); Figure 54 North America Celiac Disease Market: By Dosage Form, Cagr (2024-2031); Figure 55 North America Celiac Disease Market: By Dosage Form, Lifeline Curve; Figure 56 Europe Celiac Disease Market: By Dosage Form, 2023; Figure 57 Europe Celiac Disease Market: By Dosage Form, 2024-2031 (Usd Thousand); Figure 58 Europe Celiac Disease Market: By Dosage Form, Cagr (2024-2031); Figure 59 Europe Celiac Disease Market: By Dosage Form, Lifeline Curve; Figure 60 North America Celiac Disease Market: By Route Of Administration, 2023; Figure 61 North America Celiac Disease Market: By Route Of Administration, 2024-2031 (Usd Thousand); Figure 62 North America Celiac Disease Market: By Route Of Administration, Cagr (2024-2031); Figure 63 North America Celiac Disease Market: By Route Of Administration, Lifeline Curve; Figure 64 Europe Celiac Disease Market: By Route Of Administration, 2023; Figure 65 Europe Celiac Disease Market: By Route Of Administration, 2024-2031 (Usd Thousand); Figure 66 Europe Celiac Disease Market: By Route Of Administration, Cagr (2024-2031); Figure 67 Europe Celiac Disease Market: By Route Of Administration, Lifeline Curve; Figure 68 North America Celiac Disease Market: By Population Type, 2023; Figure 69 North America Celiac Disease Market: By Population Type, 2024-2031 (Usd Thousand); Figure 70 North America Celiac Disease Market: By Population Type, Cagr (2024-2031); Figure 71 North America Celiac Disease Market: By Population Type, Lifeline Curve; Figure 72 Europe Celiac Disease Market: By Population Type, 2023; Figure 73 Europe Celiac Disease Market: By Population Type, 2024-2031 (Usd Thousand); Figure 74 Europe Celiac Disease Market: By Population Type, Cagr (2024-2031); Figure 75 Europe Celiac Disease Market: By Population Type, Lifeline Curve; Figure 76 North America Celiac Disease Market: By End User, 2023; Figure 77 North America Celiac Disease Market: By End User, 2024-2031 (Usd Thousand); Figure 78 North America Celiac Disease Market: By End User, Cagr (2024-2031); Figure 79 North America Celiac Disease Market: By End User, Lifeline Curve; Figure 80 Europe Celiac Disease Market: By End User, 2023; Figure 81 Europe Celiac Disease Market: By End User, 2024-2031 (Usd Thousand); Figure 82 Europe Celiac Disease Market: By End User, Cagr (2024-2031); Figure 83 Europe Celiac Disease Market: By End User, Lifeline Curve; Figure 84 North America Celiac Disease Market: By Distribution Channel, 2023; Figure 85 North America Celiac Disease Market: By Distribution Channel, 2024-2031 (Usd Thousand); Figure 86 North America Celiac Disease Market: By Distribution Channel, Cagr (2024-2031); Figure 87 North America Celiac Disease Market: By Distribution Channel, Lifeline Curve; Figure 88 Europe Celiac Disease Market: By Distribution Channel, 2023; Figure 89 Europe Celiac Disease Market: By Distribution Channel, 2024-2031 (Usd Thousand); Figure 90 Europe Celiac Disease Market: By Distribution Channel, Cagr (2024-2031); Figure 91 Europe Celiac Disease Market: By Distribution Channel, Lifeline Curve; Figure 92 North America Celiac Disease Market: Snapshot (2023); Figure 93 Europe Celiac Disease Market: Snapshot (2023); Figure 94 North America Celiac Disease Market: Company Share 2023 (%); Figure 95 Europe Celiac Disease Market: Company Share 2023 (%)